PubRank
Search
About
Annemieke Geluk
Author PubWeight™ 26.00
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1.
Nature
2007
2.19
2
Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.
Proc Natl Acad Sci U S A
2007
1.75
3
Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.
Infect Immun
2007
1.33
4
Identification of specific proteins and peptides in Mycobacterium leprae suitable for the selective diagnosis of leprosy.
J Immunol
2005
1.24
5
Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects.
Cancer Res
2002
1.22
6
T-cell responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 in Brazilian tuberculosis patients.
Infect Immun
2002
1.15
7
Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy.
Mem Inst Oswaldo Cruz
2012
1.08
8
Lateral flow assay for simultaneous detection of cellular- and humoral immune responses.
Clin Biochem
2011
1.08
9
Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.
PLoS Pathog
2010
1.06
10
An unbiased genome-wide Mycobacterium tuberculosis gene expression approach to discover antigens targeted by human T cells expressed during pulmonary infection.
J Immunol
2013
1.02
11
Double- and monofunctional CD4⁺ and CD8⁺ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals.
Eur J Immunol
2011
1.01
12
Direct ex vivo detection of HLA-DR3-restricted cytomegalovirus- and Mycobacterium tuberculosis-specific CD4+ T cells.
Hum Immunol
2005
0.99
13
Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy.
Clin Vaccine Immunol
2010
0.97
14
Identification of human T-cell responses to Mycobacterium tuberculosis resuscitation-promoting factors in long-term latently infected individuals.
Clin Vaccine Immunol
2011
0.96
15
Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2.
Mol Immunol
2012
0.94
16
Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis.
Vaccine
2004
0.90
17
The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study).
BMC Infect Dis
2013
0.90
18
Pathogen-specific epitopes as epidemiological tools for defining the magnitude of Mycobacterium leprae transmission in areas endemic for leprosy.
PLoS Negl Trop Dis
2012
0.86
19
Mycobacterium leprae virulence-associated peptides are indicators of exposure to M. leprae in Brazil, Ethiopia and Nepal.
Mem Inst Oswaldo Cruz
2012
0.83
20
Peptides Derived from Mycobacterium leprae ML1601c Discriminate between Leprosy Patients and Healthy Endemic Controls.
J Trop Med
2012
0.80
21
Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells.
J Immunol
2014
0.80
22
Development of a mouse food pad model for detection of sub clinical leprosy.
Lepr Rev
2011
0.78
23
Cytokine responses to Mycobacterium leprae unique proteins differentiate between Mycobacterium leprae infected and naive armadillos.
Lepr Rev
2011
0.78
24
Interferon-gamma production in response to M. tuberculosis antigens in TB patients in Indonesia.
Adv Exp Med Biol
2003
0.77
25
Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa.
Lepr Rev
2011
0.77
26
Editor's choice December 2011.
Lepr Rev
2011
0.75
27
Report on the sixth meeting of the IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) consortium held in Beijing, China on 23-25 August 2010.
Lepr Rev
2011
0.75